ELRAVIE PREMIER DERMAL FILLERS
$70.00 – $90.00
Discover premium dermal fillers with high-purity hyaluronic acid with Elravie Premier! These fillers ensure skin vitality and restore skin elasticity in every injection, without causing discomfort due to their lidocaine content.
Each package is available in 1 x 1.0mL pre-filled syringe.
Elravie Premier Fillers is a series of premium dermal fillers that offer voluminous and long-lasting effects compared to other fillers, lasting only 3 – 6 months. The Elravie Premier Fillers have undergone a unique purification method called the TFF UF (Tangential Flow Filtration Ultra Filtration) System, which concentrates the polymer and filters out small molecular weight impurities. The filler is also void of bacteria and endotoxins that may cause unnecessary complications and side effects. The filler is manufactured aseptically via the NIA (Non-Inflammation Asepsis) method, where a membrane separation process is used to remove protein, hexane, endotoxin, and other inflammatory and exothermic substances, producing a highly purified hyaluronic acid.
The name Elravie comes from the combination of ‘Ela’ from the word elasticity and ‘Vie’ from the French word for life. Its goal is to rejuvenate and restore your skin’s vitality and elasticity. The Elravie fillers are proudly manufactured by Humedix and their innovative HI method of cross-linking hyaluronic acid. These fillers use HI (High molecular Ideal Reticulated Matrix) Technology, which cross-links hyaluronic acid from a polymer into an ideal matrix. This creates a highly efficient dermal filler with a higher degree of complex viscosity (a unit that measures the degree of total deformation against an external force) in its gel composition. Elravie Premier fillers also show superior cohesiveness and can produce varying applications. Furthermore, Elravie Premier also has a line of dermal fillers containing lidocaine, known as Elravie Premier Light-L, Elravie Deep Line-L, and Elravie Ultra Volume-L.






Reviews
There are no reviews yet.